# INCB047986 in Rheumatoid Arthritis

> **NCT02151474** · PHASE2 · TERMINATED · sponsor: **Incyte Corporation** · enrollment: 3 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** INCB047986
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02151474
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Business decision.
- **Last updated:** 2015-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02151474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02151474, "INCB047986 in Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02151474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*